Lee Ainslie - Maverick Capital
Holding/activity history for Akebia Therapeutics, Inc. (AKBA)
← All AKBA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | $2.20–3.35 · VW $2.64i | SEC | |
| 2021 Q3 | 105,816 | <0.01 | Buy | <0.01 | $2.35–3.91 · VW $2.87i | $305,000 | SEC |
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $2.74–4.33 · VW $3.46i | SEC | |
| 2021 Q1 | 140,352 | <0.01 | Buy | <0.01 | $2.76–5.14 · VW $3.57i | $475,000 | SEC |
Price snapshot:
Current price$1.38
52-week low$0.82
52-week high$4.04